A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

被引：55
|
作者：
Khiali, Sajad [1 ]
Khani, Elnaz [1 ]
Entezari-Maleki, Taher [1 ,2 ]
机构：
[1] Tabriz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2020年 / 60卷 / 09期
关键词：
acute lung injury; ARDS; CRS; COVID-19; IL-6; SARS-CoV-2; tocilizumab; DRUG-METABOLIZING-ENZYMES; SARS-CORONAVIRUS; CYTOKINE STORM; RECEPTOR; IL-6; INTERLEUKIN-6; PATHOGENESIS; INFLAMMATION; PNEUMONIA; INFECTION;
D O I：
10.1002/jcph.1693
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Currently, the world is facing the pandemic of a novel strain of beta-coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute respiratory distress syndrome (ARDS) is the most devastating complication of SARS-CoV-2. It was indicated that cytokine-release syndrome and dominantly interleukin (IL)-6 play a central role in the pathophysiology of ARDS related to the novel 2019 coronavirus disease (COVID-19). Despite the global emergency of the disease, at this time, there are no proven therapies for the management of the disease. Tocilizumab is a potential recombinant monoclonal antibody against IL-6 and currently is under investigation for the management of ARDS in patients with COVID-19. Given these points, we reviewed the current evidence regarding the potential therapeutic role of tocilizumab and its important clinical issues in the treatment of ARDS related to COVID-19.
引用
收藏
页码：1131 / 1146
页数：16
相关论文
共 50 条
  • [1] Acute Respiratory Distress Syndrome and COVID-19: A Literature Review
    Hussain, Musaddique
    Syed, Shahzada Khurram
    Fatima, Mobeen
    Shaukat, Saira
    Saadullah, Malik
    Alqahtani, Ali M.
    Alqahtani, Taha
    Bin Emran, Talha
    Alamri, Ali H.
    Barkat, Muhammad Qasim
    Wu, Ximei
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 7225 - 7242
  • [2] Acute respiratory distress syndrome in COVID-19
    Dadashzadeh, Nahid
    Farshid, Saman
    Valizadeh, Rohollah
    Nanbakhsh, Mohammad
    Rahimi, Mohsen Mohammad
    IMMUNOPATHOLOGIA PERSA, 2020, 6 (02):
  • [3] DOES TOCILIZUMAB IMPROVE SURVIVAL OUTCOME IN COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME PATIENTS?
    Wadud, Nafisa
    Ahmed, Naim
    Shergill, Mannu
    Khan, Maida
    Krishna, Murali
    Gilani, Aamir
    El Zarif, Samer
    Galaydick, Jodi
    Linga, Karthika
    Koor, Shravan
    Galea, Julia
    Stuczynski, Lauren
    Osundele, Maria
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 61 - 61
  • [4] Effect of pulsed corticosteroids and tocilizumab on hyperinflammation in COVID-19 patients with acute respiratory distress syndrome
    Aslan, Murat
    Sabaz, Mehmet Suleyman
    Yilmaz, Rabia
    Asar, Sinan
    Seker, Yasemin Tekdos
    Hergunsel, Gulsum Oya
    JOURNAL OF ACUTE DISEASE, 2021, 10 (05) : 195 - 201
  • [5] Understanding COVID-19 Acute Respiratory Distress Syndrome
    Singh, Anchit Raj
    Kumar, Raj
    Sinha, Anwita
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (01) : 150 - 150
  • [6] COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximab
    Doyle, Eileen B.
    Bentley, Darren
    Dodds, Michael G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1043 - 1053
  • [7] Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale
    Nasir, Nosheen
    Mahmood, Faisal
    Habib, Kiren
    Khanum, Iffat
    Jamil, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [8] The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19
    Azimi, Saeid
    Saghafi, Fatemeh
    Mohammadi, Mohammad Hossein
    Moghimi, Mohammad Hossein
    Akhavan, Seyed Ali
    Khataminia, Masoud
    Shirvani, Maria
    Sohrevardi, Seyed Mojtaba
    Jamialahmadi, Tannaz
    Sahebnasagh, Adeleh
    Sahebkar, Amirhossein
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (29) : 2291 - 2296
  • [9] Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?
    Maley, Jason H.
    Winkler, Tilo
    Hardin, C. Corey
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (04) : 618 - 619
  • [10] Management of Acute Respiratory Distress Syndrome in COVID-19 Patients
    Segers, J.
    Hadzic, A.
    Van Boxstael, S.
    Van Herreweghe, I
    De Fre, O.
    ACTA ANAESTHESIOLOGICA BELGICA, 2022, 73 (01) : 5 - 14
12345